Report Highlights
Liquid Biopsy Market Size And Forecast
According to Verified Market Research, The Global Liquid Biopsy Market was valued at USD 1063.71 million in 2019 and is projected to reach USD 5027.46 million by 2027, growing at a CAGR of 23.12% from 2020 to 2027.
Global Liquid Biopsy Market Overview
With the advent of technological advancement in the healthcare sector, areas of medicine such as the diagnosis and treatment through progressive technology and minimally invasive procedures have therefore grown significantly as a result. With non-invasive or minimally invasive methods in general, there are several advantages as compared to its counterpart as it involves the drastic increase in overall patient safety as well as leads to enhanced customer satisfaction through decreasing or eliminating the overall patient recovery time.
On the other hand, the lack of skilled professionals and a lack of knowledge about liquid biopsy will pose a challenge to the growth of the market at a global level.
Liquid Biopsy Market Competetive Landscape:
Liquid Biopsy Market is highly fragmented with the presence of a large number of players globally. Some of the major companies include Biocept, Inc., Qiagen, F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Myriad Genetics, Janssen Diagnostics, LLC, Trovagene Inc., Guardant Health Inc., GRAIL, and MDX Health SA.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.
Similar Reports from Verified Market Research
Global Liquid Biopsy Market
Market Overview:
The global Liquid Biopsy Market was valued at USD 576.43 million in 2016 and is projected to reach USD 3747.18 million by 2025, growing at a CAGR of 23.12% from 2017 to 2025.
Liquid biopsy is a test done on a sample of blood to look for cancer cells from a tumor that are circulating in ...
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More